|
|
||||||||

Plague, primarily a disease of rodents and their infected fleas, is fatal in 50% of infected humans if untreated. In the United States, human cases have been concentrated in the southwest. The most common modes of plague transmission are through flea bites or through contact with infected blood or tissues; however, primary pneumonic plague acquired from cats has become increasingly recognized. We report on the case investigation of a patient, presumably exposed to a plague-infected cat in Colorado, who presented with gastrointestinal symptoms, and subsequently died of primary pneumonic plague. Public health officials should be vigilant for plague activity in rodent populations, veterinarians should suspect feline plague in ill or deceased cats, and physicians should have a high index of suspicion for plague in any person who has traveled to plague enzootic areas.
* Support for publication of this article was provided by the Clinical Group of the American Society of Tropical Medicine and Hygiene.
This article is dedicated to the late Dr. John Doll, who devoted his career to combating vector-borne discases in Arizona.
This article has been cited by other articles:
![]() |
S. L. Agar, J. Sha, S. M. Foltz, T. E. Erova, K. G. Walberg, T. E. Parham, W. B. Baze, G. Suarez, J. W. Peterson, and A. K. Chopra Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92 Microbiology, July 1, 2008; 154(7): 1939 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sha, S. L. Agar, W. B. Baze, J. P. Olano, A. A. Fadl, T. E. Erova, S. Wang, S. M. Foltz, G. Suarez, V. L. Motin, et al. Braun Lipoprotein (Lpp) Contributes to Virulence of Yersiniae: Potential Role of Lpp in Inducing Bubonic and Pneumonic Plague Infect. Immun., April 1, 2008; 76(4): 1390 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Bubeck and P. H. Dube Yersinia pestis CO92{Delta}yopH Is a Potent Live, Attenuated Plague Vaccine Clin. Vaccine Immunol., September 1, 2007; 14(9): 1235 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Lawrenz and V. L. Miller Comparative Analysis of the Regulation of rovA from the Pathogenic Yersiniae J. Bacteriol., August 15, 2007; 189(16): 5963 - 5975. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Bubeck, A. M. Cantwell, and P. H. Dube Delayed Inflammatory Response to Primary Pneumonic Plague Occurs in Both Outbred and Inbred Mice Infect. Immun., February 1, 2007; 75(2): 697 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Lathem, P. A. Price, V. L. Miller, and W. E. Goldman A Plasminogen-Activating Protease Specifically Controls the Development of Primary Pneumonic Plague Science, January 26, 2007; 315(5811): 509 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Fisher, C. Castillo, and J. Mecsas Intranasal Inoculation of Mice with Yersinia pseudotuberculosis Causes a Lethal Lung Infection That Is Dependent on Yersinia Outer Proteins and PhoP Infect. Immun., January 1, 2007; 75(1): 429 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Cathelyn, S. D. Crosby, W. W. Lathem, W. E. Goldman, and V. L. Miller RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague PNAS, September 5, 2006; 103(36): 13514 - 13519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Honko, N. Sriranganathan, C. J. Lees, and S. B. Mizel Flagellin Is an Effective Adjuvant for Immunization against Lethal Respiratory Challenge with Yersinia pestis Infect. Immun., February 1, 2006; 74(2): 1113 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Lathem, S. D. Crosby, V. L. Miller, and W. E. Goldman From The Cover: Progression of primary pneumonic plague: A mouse model of infection, pathology, and bacterial transcriptional activity PNAS, December 6, 2005; 102(49): 17786 - 17791. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |